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Abstract.  The proteoglycan (PG) on the surface of 
NMuMG mouse mammary epithelial cells consists of 
at least two functional domains, a  membrane-inter- 
calated domain which anchors the PG to the plasma 
membrane,  and a trypsin-releasable ectodomain which 
bears both heparan and chondroitin  sulfate chains.  The 
ectodomain binds cells to collagen types I, 11I, and V, 
but not IV, and has been proposed to be a matrix 
receptor.  Because heparin binds to the adhesive glyco- 
proteins fibronectin,  an interstitial  matrix component, 
and laminin,  a basal lamina component, we asked 
whether the cell surface PG also binds these mole- 
cules. Cells harvested with either trypsin or EI~A 
bound to fibronectin; binding of trypsin-released cells 
was inhibited by the peptide GRGDS but not by hepa- 
rin,  whereas binding of EDTA-released cells was in- 
hibited only by a combination of GRGDS and heparin, 
suggesting two distinct cell binding mechanisms.  In 
the presence of GRGDS, the EDTA-released cells 
bound to fibron~tin via the cell surface PG. Binding 
via the cell surface PG was to the COOH-terminal 
heparin binding domain of fibronectin.  In contrast 
with the binding to fibronectin, EDTA-released cells 
did not bind to laminin  under identical assay condi- 
tions. Liposomes containing the isolated intact cell 
surface PG mimic the binding of whole calls.  These 
results indicate that the mammary epithelial cells have 
at least two distinct cell surface receptors for fibronec- 
tin:  a trypsin-resistant molecule that binds cells to the 
sequence RGD and a trypsin-labile, heparan  sulfate- 
rich PG that binds cells to the COOH-terminal hepa- 
fin binding domain.  Because the cell surface PG binds 
cells to the interstitial collagens (types I, IlL and V) 
and to fibronectin, but not to basal lamina collagen 
(type IV) or laminin,  we conclude that the cell surface 
PG is a receptor on epithelial cells specific for inter- 
stitial matrix components. 
C 
ELLULAR  behavior appears to be regulated in part by 
interactions with the extracellular  matrix.  Binding of 
insoluble extracellular  matrix proteins to cell surface 
receptors is transduced  into  specific  cellular responses by 
mechanisms  still unknown in detail. In many instances, these 
responses  both  appear  to  involve  associations  with  the 
cytoskeleton  and to occur in multiple  stages. For example, 
fibroblast adhesion to fibronectin is a multistage process in- 
volving initial cell attachment followed by cell spreading and 
the appearance of stress fibers and focal adhesions  (Heath 
and Dunn,  1978; Couchman and Rees,  1979; Thom et al., 
1979; Badley  et al.,  1980). Initial  fibroblast  attachment  to 
fibronectin  has been suggested  to involve recognition  of a 
specific tripeptide sequence RGD (Arg-Gly-Asp) via a 140- 
kD cell surface receptor complex (Pierschbacher and Ruos- 
lahti,  1984; Pytela et al.,  1985). However,  subsequent cell 
spreading,  with the development of close contacts  followed 
by focal  adhesions  and  stress fiber formation,  appears  to 
involve  interactions  between a  cell  surface  proteoglycan 
(PG) ~  and  the  heparin-binding  domain  of  fibronectin 
(Laterra et al., 1983; Lark et al.,  1985; Izzard et al.,  1986; 
Woods et al.,  1986). The evolution of the loss of close con- 
tacts and the appearance of focal adhesions  correlates with 
the cessation of fibroblast cell movement (Couchman and 
Rees, 1979), suggesting a possible cell anchoring role for the 
cell surface PG of these cells. 
These interactions  between fibroblasts and the extracellu- 
lar matrix differ markedly from those of  epithelial cells. Sim- 
ple epithelial cells exist in highly polarized sheets, bound to- 
gether  by junctional  complexes,  and  contact  the  matrix 
solely at their basal surfaces. The cells in the sheets have sta- 
1. Abbreviations used in this paper:  Ecto, ectodomain; FN, flbronectin; 
GAG, glycosaminoglycan; GdnHCI,  guanidine hydrochloride; GRGDS, 
glycine-arginine-glycine-aspartic acid-serine; HBD, heparin binding do- 
main of fibronectin; Hep, heparin; LM, laminin; NMuMG cells, normal 
murine mammary gland epithelial cells; PG, proteoglycan; SDGRG, ser- 
ine-aspartic  acid-glycine-arginine-glycine. 
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matrix. NMuMG mouse mammary epithelial cells demon- 
strate the properties of a simple epithelium, forming polar- 
ized sheets in culture (Owens et al., 1974) and ductal struc- 
tures both in vitro (Bernfield et al., 1984) and in vivo (David 
et al., 1981). Therefore, we have utilized these cells to exam- 
ine the receptors involved in the interaction of epithelial cells 
with the extracellular matrix. 
Mouse mammary epithelial cells possess a cell surface PG 
with at least two functional domains; a lipophilic membrane- 
intercalated domain and a  trypsin-releasable extracellular 
ectodomain (Rapraeger and Bernfield, 1985) that bears both 
heparan and chondroitin sulfate chains (Rapraeger et al., 
1985). Immunolocalization of adult mouse tissues with the 
monoclonal antibody 281-2 (Jalkanen et al., 1985) and with 
a  serum  antibody  (Jalkanen  et  al.,  1988) (both  directed 
against polypeptide determinants on the core protein) indi- 
cates that the antigen is on the surfaces of a wide variety of 
epithelial cells but is not on mesenchymal cells (Hayashi et 
al., 1987), and thus is a distinct gene product from the cell 
surface PG of fibroblasts. Because the mammary epithelial 
cell surface proteoglycan binds cells to fibrillar interstitial 
collagens (types I, III, and V) with high affinity and speci- 
ficity (Koda et al.,  1985), associates with the cytoskeleton 
when cross-linked in the plane of the plasma membrane 
(Rapraeger et al., 1986), and is polarized to the basolateral 
surface, we have proposed that it is a matrix receptor for in- 
terstitial collagens. 
The known affinity of heparin and heparan sulfate for 
fibronectin  (Laterra et  al.,  1980; Ruoslahti and  Engvall, 
1980; Yamada et al.,  1980; Stamatoglou and Keller,  1982; 
Fujiwara et al., 1984) and for laminin (Sakashita et al., 1980; 
Woodly et al., 1983; Fujiwara et al., 1984) suggested that the 
cell surface PG might also be an epithelial cell receptor for 
these adhesive glycoproteins. Therefore, we have assessed its 
role  in the  binding of mammary epithelial cells to these 
glycoproteins.  We  find that trypsin-released cells bind to 
fibronectin but this binding is inhibited by the synthetic pep- 
tide Gly-Arg-Gly-Asp-Ser (GRGDS),  suggesting the pres- 
ence of a receptor similar to the 140-kD fibronectin receptor 
on fibroblasts.  EDTA-harvested  cells, however,  bind to fi- 
bronectin via both this RGD receptor and the cell surface 
PG. In the presence of GRGDS, the binding of EDTA-har- 
vested cells to fibronectin is sensitive to heparan sulfate lyase 
treatment of the ceils and to competitive inhibition by both 
heparin and the purified ectodomain of the cell surface PG. 
This binding via the cell surface PG is to the COOH-terminal 
heparin binding domain of fibronectin. These binding prop- 
erties are replicated by liposomes in which purified cell sur- 
face PG has been intercalated, confirming that the cell sur- 
face PG is responsible for the binding of the cells. Under 
identical conditions, neither EDTA-released cells nor lipo- 
somes containing intercalated cell surface PG bind to lami- 
nin. These data indicate that the cell surface PG is one of at 
least two fibronectin receptors on NMuMG cells and that this 
PG binds via its heparan sulfate chains to the COOH-ter- 
minal heparin-binding domain of fibronectin. The binding to 
interstitial collagens and fibronectin and the lack of binding 
to type IV collagen and laminin suggest that the cell surface 
PG is a specific receptor.  Part of these data have been pub- 
lished in abstract form (Saunders et al.,  1986). 
Materials and Methods 
Cell Culture 
NMuMG mouse mammary epithelial cells (passages 13-22)  were main- 
tained in bicarbonate-buffered DME  (Gibco,  Grand Island,  NY)  as de- 
scribed previously (David and Bernfield, 1979). For cell binding assays, 
cells were plated on 35- or 60-ram dishes (Falcon Labware, Oxnard, CA) 
at approximately one-fifth confluent density, grown to confluency (3-4 d), 
and used within 2-3 d. For preparation of purified cell surface proteoglycan, 
cells were plated at approximately one-fifth confluent density on a 24.5  x 
24.5-cm tissue culture plate (Falcon Labware), grown to confluency,  and 
radiolabeled for 24 h  in low sulfate medium (David and Bernfield, 1979) 
containing  100 U/ml penicillin,  100  txg/ml streptomycin sulfate,  and  100 
laCi/ml  35SO4 (ICN Biomedicals Inc., Irvine, CA). 
Cell Binding Assay 
This assay is based on a technique designed to test for the reaction of cell 
surface antigens with mAbs (Eisenbarth et al.,  1980) and has been previ- 
ously used to demonstrate the binding of NMuMG cells to various intersti- 
tial collagens (Koda et al., 1985).  PVC multiwells (U-shaped bottom, Dy- 
natech Corp., Alexandria, VA) were coated with proteins by incubating PBS 
(134 mM NaCl, 2.7  mM KCI, 8.1  mM Na2HPO4,  1.5 mM KH2PO4, pH 
7.4) solutions of the desired protein (BSA, 10 mg/ml; fibronectin, 50 p.g/ml; 
heparin binding domain, 15 Ixg/ml; laminin, 100 p.g/ml) with the wells over- 
night at 4~  Remaining binding sites were saturated before the binding as- 
say by incubating the wells for 1 h at room temperature with 1 mg/ml BSA 
in  PBS  (buffer  A).  The  media  was  removed  from  newly  confluent 
monolayers of NMuMG cells and the cells were washed twice with cold 
(4~  PBS plus 0.5 mM disodium EDTA (buffer B). Cells were harvested 
by either trypsinization or EDTA rounding and scraping. 
For trypsinization cells on the washed monolayer were detached by 100 
~tg/ml trypsin (Gibco) in Tris-EDTA at room temperature. After detachment 
(5-10 min), the trypsinization was stopped by addition of 500 ~tg/ml soybean 
trypsin inhibitor (Calbiochem-Behring Corp., La Jolla, CA) and the cells 
transferred to a chilled centrifuge tube. After two washes by suspension and 
centrifugation (2 min, 240 g) in a clinical centrifuge (International Equip- 
ment Co., Needham Heights, MA), the cells were resuspended at •3.5  ￿ 
10  ~ cells/ml in cold (40C)  buffer A by pipetting until well dispersed. 
For EDTA rounding-cell scraping, cells on the washed monolayer were 
rounded by a  10-min incubation with buffer B at room temperature. After 
carefully removing the buffer B from the rounded cells, the plate was placed 
on ice and the cells gently scraped into cold (4~  buffer B using a rubber 
policeman. The scraped cells were gently washed at 4~  as just described, 
dispersed on ice by pipetting, and resuspended at ,,o3.5  ￿  105 cells/ml in 
buffer A. Suspension at cold temperatures prevents the shedding of the cell 
surface PG, as described elsewhere (Jalkanen et al.,  1987). 
Cell binding was assayed by pipetting 200 Ixl of the cell suspension into 
each well and incubating the cells with the wells for 30 min at room temper- 
ature.  The microtiter plate was then centrifuged 15 min (Dynatech plate 
holder) at  800 rpm in a  model UV centrifuge (International Equipment 
Co.). After centrifugation, 50 p.l of 4% glutaraldehyde in PBS was added 
to each well and the plates fixed overnight at room temperature. The cells 
were then stained with trypan blue (Gibco) in PBS and photographed. If 
cells bind to the well, they remain as a uniform coating covering the bottom 
surface of the well; if the cells do not bind, they form a pellet at the bottom 
of the well. 
Inhibitors of Cell Binding 
To assay for the effect of heparin, we pretreated protein-coated wells with 
heparin before the addition of the cell suspension. After incubation with 
buffer A, the protein-coated wells were rinsed once with and subsequently 
incubated with  10  p.M heparin (Upjohn Co., Kalamazoo, MI; beef lung 
10,000 mol wt average,  thrice precipitated with ethanol) in buffer A for 30 
min at room temperature. The heparin solution was removed before addition 
of the cell suspension. 
The  ectodomain  of  the  cell  surface  proteoglycan,  prepared  from 
NMuMG cell conditioned media by DEAE chromatography, CsCI2 den- 
sity centrifugation, and mAb affinity chromatography as described else- 
where (Jalkanen et al.,  1987), was assayed as for heparin. 
The effects of the synthetic peptides GRGDS and SDGRG (generously 
supplied  by  Dr.  Russell  Doolittle,  Dept.  of Chemistry,  University  of 
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concentrations indicated, to the cell suspension before its introduction into 
the protein-coated wells. 
For heparitinase treatment, before harvesting the cells by EDTA rounding 
and scraping as just described, the washed monolayer was treated for 15 min 
at 37"C  with 0.1  U/ml Flavobacterium  heparinum beparitin sulfate lyase 
(heparitinase, Miles Laboratories Inc.,  Naperville,  IL) in PBS containing 
0.1%  BSA and  1.25  mM CaCI2.  In addition, 0.1  U/ml of enzyme was in- 
cluded in the cell suspension during incubation of the cells with the wells. 
Purification Of  Human Plasma Fibronectin 
and Its Fragments 
Fibronectin was prepared from human plasma by affinity chromatography 
on galatin-Sepharose as described previously  (Miekka et al.,  1982).  The 
purified fibronectin was concentrated, as necessary, by dialysis against 30% 
polyethylene glycol (Baker,  20,000 mol wt) in PBS. 
The COOH-terminal heparin binding domain of fibronectin was prepared 
as described (Zardi et al.,  1985).  Briefly, purified fibronectin (ca.  30 mg 
at 1 mg/ml) in 25 mM Tris/HCl pH 7.6, containing 0.5 mM EDTA, 50 mM 
NaCI,  and 2.5 mM CaCI2 was digested with 5  Ixg/ml thermolysin (Sigma 
Chemical Co.,  St. Louis, MO) for 4  h at room temperature. After adding 
EDTA to a final concentration of 5 mM, the digestion products were dia- 
lyzed against 0.5  mM  sodium phosphate containing 0.1%  sodium azide, 
pH 6.8, and purified by hydroxyapatite (Bio-Rad Laboratories, Richmond, 
CA) chromatography (1.5  ￿  18-cm column, at 15 ml/h), using a 0.5-190 
mM linear gradient ofpH 6.8 sodium phosphate, 0.1% sodium azide. Frac- 
tions  containing  the  COOH-terminal  heparin  binding  domain  were 
identified by polyacrylamide gel electrophoresis, pooled, dialyzed against 
PBS, and stored at  -70~ 
Preparation Of  Liposome Intercalated Cell 
Surface Proteoglycan 
A radiolabeled 24.5  x  24.5-cm monolayer of NMuMG cells was washed 
three times in cold (4~  Tris-buffered (Sigma Chemical Co.,  10 mM, pH 
7.4) isotonic saline, containing 1.25  mM CaC12 and 0.9 mM MgSO4.  The 
monolayer was then scraped and washed twice in cold (4~  Ca  2+, Mg  2+- 
free Tris-buffered saline plus 0.5 mM disodium EDTA. The cells were sus- 
pended in 5 ml Tris-acetate buffered saline (TAS;  10 mM Tris, 50 mM so- 
dium acetate, 150 mM sodium chloride, 5 mM EDTA,  I mM phenylmethyl- 
sulfonyl fluoride,  5  mM N--ethylmaleimide, 5  mM benzamidine) pH 5.0, 
containing 75 mM octyl glucoside (Calbiochem-Behring Corp.) for 10 min 
on ice. The detergent-extracted residue was centrifuged (100 g, 5 rain) and 
resuspended in TAS containing 75 mM octyl glucoside and 0.5 M  KCI for 
10 rain on ice. 
The KC1 extract,  which contains the cell surface PG (Rapraeger et al., 
1986), was diluted fivefold with 6  M  urea (Schwarz-Mann,  Spring Valley, 
NY), 50 mM sodium acetate pH 4.5 (Schwarz-Mann), 75 mM octyl gluco- 
side,  and  subjected  to  DEAE  chromatography  at  4~  A  1-ml  DEAE- 
Sephacei  column  (Pharmacia Fine Chemicals,  Piscataway,  NJ)  preequil- 
ibrated with 6 M  urea, 0.4 M  NaCI,  50 mM sodium acetate, pH 4.5, and 
50 mM octyl glucoside (buffer D), was loaded at 8 rrd/h and then washed 
sequentially with 6 ml of buffer D, followed by 6 ml buffer D without urea. 
The  35S-labeled  cell  surface  proteoglycan  was  eluted  with 0.8  M  NaC1, 
50 mM sodium acetate,  pH 4.5,  and 50 mM octyl glucoside. 
The  cell  surface  PG  was  further purified  on  a  mAb  immunoaffinity 
column (1 mg/m1281-2, linked to CNBr-Sepharose) (Jalkanen et al.,  1985). 
The fraction from DEAE was diluted fivefold with 50 mM Tris pH 7.4, 50 
mM  octyl  glucoside  and  loaded  at  20  ml/h  on  a  2.5  x  3.5-cm  im- 
munoaffinity column preequilibrated with 50 mM Tris, pH 7.4, 50 mM oc- 
tyl glucoside, and 0.15 M  NaCI.  The immunoaffinity column was washed 
with 15 ml of the equilibration buffer and then eluted with 50 mM triethyl- 
amine, pH  11.4, containing 50 mM octyl glucoside. The eluted 35S-labeled 
cell surface PG was immediately neutralized with a one-tenth volume of 1 M 
Tris,  pH  7.4.  Purity  was assessed by polyacrylamide gel electrophoresis 
(Koda et al.,  1985). 
Purified 35S-labeled  cell surface PG was intercalated into liposomes as 
described previously (Rapraeger and Bernfield,  1985).  Briefly, the 35S-la- 
beled PG in 4  M  GdnHCI (Schwarz-Mann), 50 mM Tris (pH 8.0),  0.1  M 
NaCI (buffer E) containing 75 mM octyl glucoside, was brought to 5 mg/ml 
with soybean phospholecithin (Sigma Chemical Co.) in buffer E containing 
75 mM octyl glucoside. Liposomes were allowed to form by overnight dialy- 
sis against buffer E,  and subsequently dialyzed against buffer A  for use. 
Figure 1.  Trypsin-released  ceils bind  to  fibronectin  via  an  RGD 
mechanism. NMuMG cells grown to confluency and released with 
trypsin as described in Materials and Methods do not bind to BSA 
(A), but bind to fibronectin  (FN) (B). Heparin (Hep) (C) and the 
control peptide SDGRG (D) do not inhibit  cell binding.  However, 
binding to fibronectin  is inhibited by the pentapeptide  GRGDS con- 
mining the RGD binding  sequence (E). 
Solid Phase Binding Of  Liposomes Containing 
Cell Surface Proteoglycan 
Individual  PVC  wells  (Dynatech)  were  coated  and  preincubated  as  de- 
scribed for the cell binding assay above. The preincubation solution (with 
or without heparin) was removed and 50 ~tl of liposomes containing 35S- 
PG (10,000 cpm/well, Fig. 7, or 6,000 cpm/well Fig. 9) in buffer A added, 
and incubated for 2.5 h  at room temperature.  After incubation,  the pro- 
teoglycan solution was removed and the wells washed five times with buffer 
A.  The amount of 35S-PG bound was quantitated by cutting out the wells, 
placing them in Aquasol scintillant and counting directly in a model LS-7500 
scintillation counter (Beckman Instruments Inc.,  Pullerton, CA). 
Results 
NMuMG Epithelial Cells Possess  More Than One 
Cell Surface Receptor for Fibronectin 
The 140-kD cell surface complex that binds to a region of 
fibronectin containing the sequence Arg-Gly-Asp (RGD) is 
not removed from fibroblast cell surfaces by trypsin treat- 
ment (Tarone et al., 1982; Giancotti et al., 1985). To evaluate 
whether epithelia show similar binding properties,  we as- 
sessed the binding of trypsinized NMuMG cells to fibronec- 
tin (Fig. 1). NMuMG cells harvested with 100 Ixg/ml trypsin 
in EDTA bind to fibronectin via the RGD sequence (Fig.  1 
B). Binding to fibronectin was not inhibited by pretreatment 
of the wells with 10 ~tM heparin (Fig. 1 C). However, bind- 
ing was inhibited by the synthetic peptide Gly-Arg-Gly-Asp- 
Ser (GRGDS) (Fig.  1 E),  but not by the peptide Ser-Asp- 
Gly-Arg-Gly (SDGRG)  (Fig.  1 D).  Trypsin-released cells 
that were subsequently incubated for 45 min at 37~  in com- 
plete medium behaved identically (data not shown). There- 
fore, trypsinized NMuMG cells appear to bind similarly as 
the trypsinized fibroblastic cells, viz. via a receptor for an 
RGD sequence in fibronectin. 
Trypsin treatment removes many integral and peripheral 
membrane proteins from cells, including fibronectin (Ruos- 
lahti et al., 1982) and a cell surface PG (Rapraeger and Bern- 
field,  1985). To assess whether trypsin treatment modifies 
the binding of NMuMG cells to fibronectin, the cells were 
harvested following rounding with EDTA (Fig. 2). NMuMG 
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and  a  heparin-sensitive  mechanism.  NMuMG  cells  grown  to 
confluency and released with EDTA, as described in Materials and 
Methods, do not bind to BSA (A) but bind to fibronectin (FN) (B). 
However, unlike trypsin-released cells, binding is not inhibited by 
GRGDS alone (C, D, and E), even at a concentration twice that 
which inhibits the binding of trypsin-released cells. After pretreat- 
ment of fibronectin-coated wells with heparin (Hep), cell binding 
is inhibited at 1,000 ~tM GRGDS (F). 
cell monolayers were incubated for 10 min in EDTA at room 
temperature, placed at 4~  then scraped and dispersed into 
a cell suspension in cold buffer. These cells bound to fibro- 
nectin (Fig. 2 B), but the binding was via a mechanism that 
is  distinct from that  of the  trypsin-released cells.  Unlike 
trypsin-released cells,  the binding of EDTA-released cells 
was unaffected by the addition of GRGDS at concentrations 
up to 2,000 ~tM (Fig. 2, C-E), twice that which readily in- 
hibits  the  binding  of  trypsin-released  cells.  However, 
GRGDS  did  inhibit  binding  when  the  fibronectin  was 
pretreated with 10 I~M heparin (Fig. 2 F). Thus, the EDTA- 
released cells apparently bind to fibronectin differently than 
the trypsin-released cells. 
NMuMG Cells Bind to Fibronectin  via 
the Cell Surface Proteoglycan 
NMuMG cells possess a cell surface PG that is cleaved from 
the cells by mild proteolysis (Rapraeger and Bernfield, 1985) 
and which binds the cells to interstitial collagens (Koda et 
al.,  1985). We investigated whether the cell surface PG also 
binds these epithelial cells to fibronectin. To test this possi- 
bility, EDTA-released cells were incubated with fibronectin. 
As  expected,  treatment  with  GRGDS did  not inhibit cell 
binding (Fig. 3 B) except after pretreatment of the fibronec- 
tin with heparin (Fig. 3 C). This effect of heparin was dupli- 
cated by pretreatment of the fibronectin with the purified ec- 
todomain  of the  cell  surface  PG  at  0.4  lxM  (Fig.  3  E), 
suggesting that the heparan sulfate glycosaminoglycan (GAG) 
chains of the cell surface PG mediate the binding.  Indeed 
treatment of NMuMG cells with heparan sulfate lyase (hepa- 
ritinase), which preserves the integrity of the proteoglycan 
core protein while degrading the heparan sulfate GAG chains 
(Rapraeger et al., 1986), causes cell binding to become sus- 
ceptible to  GRGDS  in  a  dose-dependent fashion  (Fig.  4, 
C-F). Therefore, binding of NMuMG cells to fibronectin is 
mediated both by a  trypsin-resistant cell surface molecule 
that recognizes the RGD sequence and by a trypsin-sensitive 
heparan sulfate PG. 
NMuMG Cells Bind to the COOH-terminal Heparin 
Binding Domain of  Fibronectin  via the Cell Surface PG 
Fibronectin has two sites that bind heparin, a lower affinity, 
divalent cation dependent site at the NH2-terminus and  a 
higher  affinity  site  at  the  COOH  terminus  (Hayashi  and 
Yamada,  1982).  Binding of NMuMG cells via the cell sur- 
face PG occurs in the absence of divalent cations suggesting 
that the NH2-terminal site is not involved and that this bind- 
ing is to the high affinity site. To evaluate this possibility we 
purified the COOH-terminal heparin binding domain from 
thermolysin digests of fibronectin. EDTA-released NMuMG 
cells bound to the heparin binding domain (Fig. 5 B) but, 
in contrast with intact fibronectin, binding was inhibited by 
pretreatment with  10 IxM heparin (Fig.  5  C) and was  un- 
affected by GRGDS (Fig. 5 D). The COOH-terminal heparin 
binding domain from chymotryptic digestion of fibronectin 
yielded identical results  (data not shown).  These observa- 
tions indicate that the binding of the NMuMG cells via the 
cell surface PG is mediated by the COOH-terminal heparin 
binding domain. 
Liposomes Containing Intercalated Cell Surface 
Proteoglycan Mimic the Binding Properties of 
NMuMG Cells 
The ability of the isolated ectodomain and intact cell surface 
PG to bind to fibronectin was investigated to assess whether 
either duplicated  the  binding  properties of the  cells.  Al- 
though able to inhibit cell binding to fibronectin at high con- 
centration, the isolated ectodomain of the cell surface PG 
bound poorly to fibronectin in a solid-phase assay (data not 
shown). Therefore, the binding of liposomes containing in- 
tercalated intact cell surface PG was examined.  The lipo- 
somes bound to fibronectin (Fig. 6 B), but not to BSA (Fig. 
6 A). This binding was inhibited by heparin pretreatment of 
the wells (Fig. 6 C), but was unaffected by GRGDS (Fig. 6 
D).  Furthermore,  binding  of  liposomes  to  the  COOH- 
terminal heparin binding domain (Fig. 6 E) was inhibited by 
pretreating the wells  with heparin  (Fig.  6  F).  Therefore, 
Figure 3. The extracellular domain (ectodomain) of the cell surface 
PG mimics heparin.  EDTA-released cells,  as in Fig. 2, bind to 
fibronectin (FN) (A) and this binding is not inhibited by GRGDS 
alone (B). When the fibronectin is pretreated with heparin (Hep), 
GRGDS treatment results in complete inhibition of binding (C). 
The purified ectodomain (Ecto) of the cell surface PG mimics this 
effect of heparin in a dose-dependent manner (D, E). 
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released  cells  from binding  via the  cell  surface  proteoglycan. 
EDTA-released cells, as in Fig. 2, do not bind to BSA (A), but do 
bind to fibronectin (FN) both before (B) and after removal of cell 
surface heparan  sulfate with heparan  sulfate lyase (heparitinase) 
(C). After removal of cell surface heparan sulfate, binding of EDTA- 
released cells is inhibited by GRGDS in a dose-dependent manner 
(D, E, and F). 
liposomes containing the isolated cell surface PG mimics the 
binding of EDTA-released cells. 
Cell Surface Proteoglycan Does Not Bind NMuMG 
Cells to Laminin 
Laminin is another adhesive glycoprotein reported to have 
heparin and heparan sulfate binding activities (Sakashita et 
al., 1980; Woodly et al., 1983; Fujiwara et al., 1984). There- 
fore, we investigated whether the cell surface PG of mouse 
mammary epithelial cells mediates cell binding to laminin. 
EDTA-released NMuMG cells bound to fibronectin (Fig.  7 
C) and native type I collagen (Fig. 7 B) as reported previ- 
ously (Koda et al., 1985), but failed to bind to laminin-coated 
wells (Fig. 7 D). This result was obtained with three distinct 
laminin preparations and at laminin concentrations sufficient 
to demonstrate the adhesion of a variety of other cell types 
(Goodman and Newgreen,  1985). 
Liposomes containing intercalated cell surface PG dupli- 
cated the binding of cells;  liposomes bound to  fibronectin 
(Fig.  8 B) and to native type I collagen (Fig.  8  C), but not 
Figure  6.  Liposomes  containing  the  cell  surface  proteoglycan 
mimic the binding of cells  to fibronectin.  The cell  surface pro- 
teoglycan of mouse mammary epithelial cells was metabolically la- 
beled with 35SO4. Proteoglycan  was extracted  with Triton X-100 
containing 0.5 M KCI, purified by DEAE and immunoaflinity chro- 
matography, and  intercalated into liposomes.  10,000 cpm of 35S- 
PG was added to each well and incubated for 2.5 h as described 
in Materials and Methods. The liposomes do not bind to BSA (A), 
but bind to fibronectin (FN) (B) and to the isolated COOH-terminal 
heparin binding domain (HBD) (E). This binding was inhibited by 
heparin (Hep) (C and F), but not by GRGDS (D). 
to BSA  (Fig.  8  A) or  to laminin-coated wells  (Fig.  8  D). 
Therefore we conclude that NMuMG cells do not bind to 
laminin via the cell surface PG. 
Discussion 
The binding of cells to extracellular matrix has been exten- 
sively evaluated but,  in most instances,  these studies have 
evaluated the behavior of fibroblastic cells. These cells mi- 
grate through the matrix in which they are embedded and 
have a different relationship with their extracellular matrix 
than epithelial cells which normally are sessile and interact 
with matrix components solely at their basal surfaces. We 
have evaluated the binding of NMuMG mouse mammary ep- 
ithelial cells to the adhesive glycoproteins fibronectin, an in- 
terstitial  matrix  component,  and  laminin,  a  basal  lamina 
component. We find that these cells possess at least two dis- 
tinct  cell  surface  receptors  for  binding  to  fibronectin:  a 
trypsin-resistant  receptor  that  binds  cells  to  the  sequence 
RGD and a trypsin-labile, heparan sulfate-rich PG that binds 
cells to the COOH-terminal heparin binding domain. Under 
the conditions where the cells bind to fibronectin via the cell 
surface PG, the cell surface PG does not mediate the binding 
of the cells to laminin.  Because the cell surface PG binds 
cells to the interstitial collagens (types I, III, and V),  and 
Figure 5. Cells bind to the COOH-terminal heparin binding domain 
of fibronectin  via the  cell  surface proteoglycan.  EDTA-released 
mammary epithelial cells, as in Fig. 2, do not bind to BSA (A), but 
bind  to  the  purified  COOH-terminal  heparin  binding  domain 
(HBD) of fibronectin  (B).  This  binding  is  inhibited  by heparin 
(Hep) (C), but not by the RGD-containing peptide GRGDS (D). 
Figure  7.  EDTA-released cells do  not  bind  to  laminin.  EDTA- 
released cells, as in Fig. 2, do not bind to BSA (A), but bind to type 
I collagen (B) and fibronectin (FN) (C). However, under identical 
assay conditions,  these cells do not bind to laminin (LM) coated 
wells (D). 
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not bind to laminin. Liposomes containing the cell surface pro- 
teoglycan  were prepared as in Fig. 7. 6,000 cpm 35S-PG was added 
to each well and incubated for 2.5 h as described in Materials and 
Methods. The liposomes bind to fibronectin (FAr) (B) and to type 
I eoUagen (C) but not to BSA (A) or to laminin (LM) (D). 
fibronectin, but not to basal lamina collagen (type IV) or 
laminin, we conclude that the cell surface PG binds these ep- 
ithelial cells specifically to interstitial matrix components. 
Cell Surface PG as a Fibronectin Receptor 
The binding of NMuMG cells to fibronectin depends on the 
method of  harvesting the cells from monolayer cultures. The 
binding of trypsin-released NMuMG cells to fibronectin is 
inhibited by a peptide containing the RGD sequence, identi- 
cal with that of a variety of similarly harvested fibroblastic 
ceils (Pierschbacher and Ruoslahti, 1984). Moreover, a se- 
rum antibody to the 140-kD complex (anti GP-140) stains the 
surfaces  of these  NMuMG cells and blocks  their  RGD- 
dependent binding (unpublished), suggesting that this bind- 
ing is via the 140-kD complex. Because trypsin treatment re- 
moves the cell surface PG (Rapraeger and Bernfield, 1985) 
and the binding of trypsinized NMuMG cells to fibronectin 
is prevented by the RGD peptide, the 140-kD RGD receptor 
appears to be the sole functional fibronectin receptor on tryp- 
sinized cells under our assay conditions. 
NMuMG cells harvested with EDTA bind to fibronectin  by 
two receptors,  the  140-kD  RGD receptor and one that is 
prevented from binding by two types of pretreatment, pre- 
treatment of  the cells with heparitinase or pretreatment of  the 
fibronectin with either heparin or the soluble ectodomain of 
the cell surface PG.  Both EDTA-harvested NMuMG cells 
and liposomes containing the intact cell surface proteoglycan 
bind  to  the  COOH-terminal  heparin  binding  domain of 
fibronectin in a  heparin-sensitive and GRGDS-insensitive 
manner. These data indicate that the cell surface PG acts as 
a fibronectin receptor on these cells. 
Heparinlike polysaccharides are known to bind to fibro- 
nectin. The binding of heparin to fibronectin was among its 
earliest  established  properties  (Stat,hakis  and  Mosesson, 
1977; Laterra et al.,  1980) and this binding occurs under 
physiological conditions to discrete proteolytic fragments 
(Yamada et al., 1980). Binding ofheparin to fibronectin also 
appears to increase the affinity  of  the fibronectin for collagen 
(Johansson and Hook, 1980; Ruoslahti and Engvall, 1980), 
possibly the result of conformational changes in fibronectin 
(Osterlund et al.,  1985). 
Although several studies have described the interactions of 
PGs with fibronectin involving heparan sulfate chains (Hed- 
man et al., 1982; Oldberg and Ruoslahti, 1982; Fujiwara et 
al., 1984), interactions of PGs involving chondroitin sulfate 
chains (Oldberg and Ruoslahti, 1982; Yamagata et al., 1986) 
and the core protein (Isemura et al.,  1987; Schmidt et al., 
1987) also have been observed. Most of these previous stud- 
ies have involved PGs extracted from the extracellular and 
pericellular matrix. 
The possibility that a cell surface-associated PG binds to 
fibronectin was suggested by the findings that beparan sulfate 
PG purified from rat liver microsomes binds to fibronectin 
in a column assay (Robinson et al., 1984) and that fibroblasts 
adhere to fibronectin via a heparinlike molecule (Laterra et 
al.,  1983; Lark et al.,  1985; Izzard et al.,  1986; Woods et 
al.,  1986). In the present study, cell binding experiments 
suggested the involvement of a cell surface PG and reconsti- 
tution  of  the  purified  cell  surface  PG  into  liposomes 
confirmed that this molecule mediates the binding of the 
cells. 
Although the cell surface PG bound liposomes to fibronec- 
tin in a solid-phase assay, in this assay the isolated ectodo- 
main of the cell surface PG bound poorly to fibronectin but 
was able to inhibit cell binding at high concentration. This 
behavior of the PG is consistent with the behavior of other 
isolated matrix receptors. For example, the isolated receptor 
anchorin CII binds with low affinity and poor selectivity to 
type II collagen. When intercalated into liposomes, however, 
anchorin CII binds with higher affinity and is selective for 
type II collagen (von der Mark et al.,  1984). These results 
suggest that mobility of the PG in the plane of  the membrane 
contributes to its affinity for fibronectin. 
Cell Surface Proteoglycan Binds Cells 
to Interstitial Matrix Components 
The cell surface PG polarizes solely to the basolateral sur- 
face of NMuMG cells in culture (Rapraeger et al.,  1986). 
This distribution duplicates the localization of the cell sur- 
face proteoglycan on various simple epithelia in adult tissues 
in vivo (Hayashi et al., 1987) and is consistent with its pro- 
posed function as a matrix receptor. Despite the immediate 
proximity of the cell surface PG to the basal lamina, no bind- 
ing of this molecule to the isolated basal lamina components 
laminin (this study) or type IV collagen (Koda et al., 1985) 
is observed, even when the cell surface PG is intercalated 
into liposomes, a procedure that is necessary to demonstrate 
binding to fibronectin. In contrast, the cell surface PG binds 
to components of the interstitial matrix such as fibronectin 
(this study), and types I, 1II, and V collagens (Koch et al., 
1985). Therefore, at least under the conditions of our assay, 
we conclude that the cell surface proteoglycan is specific for 
components of the interstitial matrix. 
We have proposed that the cell surface PG serves as an in- 
terstitial matrix anchor for epithelial cells. Interstitial matrix 
does exert behavioral influences on epithelial cells. For ex- 
ample, an interstitial matrix substratum (interstitial colla- 
gens and fibronectin) appears to stabilize epithelial sheets in 
vitro and may enhance the accumulation of specific differen- 
tiated gene products (Haeuptle et al., 1983; Hay, 1985). De- 
velopment of stable epithelial morphology in vivo correlates 
with the deposition of interstitial matrix at the basal epithe- 
lial surface in mouse embryo salivary glands 03ernfield et 
al.,  1984). This matrix anchoring hypothesis predicts that 
the cell surface PG extends through the epithelial basal lam- 
ina to interact with interstitial matrix, a prediction that is cur- 
rently being tested. 
Significance of  Multiple Fibronectin Receptors 
NMuMG cells contain at least two cell surface molecules 
that bind fibronectin, the 140~kD RGD receptor, and the cell 
surface PG. The presence of a single cell type bearing more 
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ple,  both  the  140-kD  complex and  a  45-kD  receptor for 
fibronectin (Aplin et al.,  1981; Hughes et al.,  1981; Oppen- 
heimer-Marks and Grinnell, 1984) are present on Swiss 3T3 
cells  (Urushihara  and  Yamada,  1986).  However, it is  not 
known  whether distinct matrix receptors that bind  to the 
same ligand on a single cell type are independent and appar- 
ently redundant binding mechanisms or whether they coop- 
erate or interact. 
Fibronectin consists of a heterogeneous family of  polypep- 
tides  resulting  from  the  alternate  splicing  of its  mRNA 
(Schwarzbauer et al., 1983; Kornblihtt et al., 1984; Schwarz- 
bauer et al.,  1985; Paul et al.,  1986). Whereas the timing of 
expression and tissue localization of these various fibronec- 
tin forms have not been identified, they likely possess some 
unique biological attributes (Humphries et al.,  1986). All of 
the  alternate  peptide  inserts  thus  far  identified  fall  into 
regions either between the RGD containing and COOH-ter- 
minal heparin binding domains, or immediately adjacent to 
these domains (Schwarzbauer et al., 1983; Paul et al., 1986). 
A  single inserted peptide between these domains  is found 
only  in  cellular  fibronectin  (Schwarzbauer  et  al.,  1983; 
Kornblihtt et al.,  1984).  Thus, it is reasonable to speculate 
that cells containing both the  140-kD  and cell surface PG 
receptors for fibronectin may respond distinctly to these dis- 
tinct forms of fibronectin. The peptide linking the RGD-con- 
raining  and the  COOH-terminal  heparin binding  domains 
may  allow  cooperative interactions to  occur between  the 
fibronectin receptors. For example, Balb/c 313 cells, which 
are thought to contain both the 140-kD and a cell surface PG 
receptor, fail to form focal adhesions on substrata containing 
a mixture of the isolated RGD-containing and COOH-termi- 
nal heparin binding domains (Izzard et al.,  1986). 
Simple epithelial cells exist in vivo as single layers of cells 
in sheets or cords with the cells linked to one another by vari- 
ous types of cell junctions and cell adhesion molecules. In 
adult tissues, these cell sheets are relatively stable and the 
cells do not move or undergo changes in cell shape. The pres- 
ence on epithelial cells of both the 140-kD and the cell sur- 
face PG fibronectin receptors may be understood by postulat- 
ing distinct roles for such receptors in epithelial behavior. 
When the cell sheet is stable, we postulate that the cell sur- 
face  PG  is  involved  in  stabilizing  these  linkages  to  the 
fibronectin-containing interstitial matrix.  However, should 
an injury cause a defect or discontinuity in the sheet, the epi- 
thelial cells at the margins will spread and begin to migrate 
laterally to fill the defect (Kolega, 1986), a behavior that we 
postulate involves the 140-kD receptor. Consistent with these 
postulates, when NMuMg epithelial cells lose their attach- 
ment to the substratum in vitro they quantitatively shed the 
cell surface PG by cleavage of the GAG-bearing ectodomain 
from  the  membrane-associated  domain  (Jalkanen  et  al., 
1987).  In  contrast,  expression of the  140-kD  receptor on 
these cells is unaffected by suspension. The loss of the cell 
surface PG in vivo would loosen cell anchorage to the inter- 
stitial matrix via the cell surface PG but allow spreading and 
subsequent migration of the epithelial cells on this matrix 
substratum. 
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